News

Off-label Low-Dose Naltrexone Reduced Fibromyalgia Pain


 

FROM THE ANNUAL MEETING OF THE AMERICAN ACADEMY OF PAIN MEDICINE

Approximately 5% of U.S. women and 2% of men are thought to have fibromyalgia.

Dr. Younger reported having no financial disclosures. Funding for the study came primarily from the American Fibromyalgia Syndrome Association, with other support from Jim and Connie Binns, the Oxnard Foundation, the Chris Redlich Pain Research Endowment, and the Rosekran Pain Research Endowment.

Pages

Recommended Reading

Measures of RA Progression Remain Flawed Predictors of Outcomes
MDedge Rheumatology
RA Patients Have Made Treat-to-Target Personal
MDedge Rheumatology
Transdermal Opioid Eases Low Back Pain
MDedge Rheumatology
Prescribing Opioids for Pain Requires Careful Approach
MDedge Rheumatology
Spine Pain + Fibromyalgia Flag Resistance to Standard Therapy
MDedge Rheumatology
Acupuncture Flops as Relief for Muscle Pain From Aromatase Inhibitors
MDedge Rheumatology
FDA Issues One REMS for All Transmucosal Fentanyl
MDedge Rheumatology
Spot Lumbar Spinal Stenosis From Across the Room
MDedge Rheumatology
Physicians Often Missing Boat on Gout Therapy
MDedge Rheumatology
Less NSAIDs for Arthritis Equals More Falls
MDedge Rheumatology